Transcription of Updated Guidelines for Antiretroviral Postexposure ...
{{id}} {{{paragraph}}}
Updated Guidelines for Antiretroviral Postexposure prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV United States, 2016 from the Centers for Disease Control and Prevention, Department of Health and Human Services Update: Interim Statement Regarding Potential Fetal Harm from Exposure to Dolutegravir Implications for HIV Post-exposure prophylaxis (PEP). Please see attached nPEP Guidelines Update Page 2 of 91 Disclaimers: All material in this publication is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
Updated Guidelines for Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV— United States, 2016
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}